Craft
ConvaTec

ConvaTec

Countries

100

H1, 2022

Revenue

$2 B

FY, 2021

Market Capitalization

£4.3 B

2022-11-09

ConvaTec Summary

Company summary

Overview
ConvaTec Group is a medical products and technologies company focused on solutions for the management of chronic conditions. It provides products used for chronic and acute wound care, ostomy care, continence and critical care, and infusion care used in the treatment of diabetes and other conditions.
Type
Public
Status
Active
Founded
1978
HQ
Reading, GB | view all locations
Website
https://www.convatec.com/
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key people

  • Karim Bitar

    Karim Bitar, Chief Executive Officer and Director

  • Jonny Mason

    Jonny Mason, Chief Financial Officer

  • David Shepherd

    David Shepherd, President and Chief Operating Officer, Global Advanced Wound Care

  • Kjersti Grimsrud

    Kjersti Grimsrud, President and Chief Operating Officer, Infusion Care

Operating MetricsView all

Countries

100

H1, 2022

Consumers (Me+ Programme)

300K

FY, 2019

Manufacturing Facilities

9

FY, 2021

LocationsView all

67 locations detected

  • Reading, England HQ

    United Kingdom

    3 Forbury Place, Forbury Estate, 23 Forbury Road

  • Bridgewater Township, NJ

    United States

    200 Crossing Blvd #101

  • Greensboro, NC

    United States

    7815 National Service Rd #600

  • Oklahoma City, OK

    United States

  • Buenos Aires, CABA

    Argentina

    Cerrito 1070 Piso 3

  • Melbourne, Victoria

    Australia

    Level 2, Building 5, Brandon Business Park, 530 Springvale Road, Brandon Park

and 61 others

ConvaTec Financials

Summary financials

Revenue (H1, 2022)
$1.0B
Gross profit (H1, 2022)
$675.7M
Net income (H1, 2022)
$48.3M
Cash (H1, 2022)
$271.6M
EBIT (H1, 2022)
$81.3M
Enterprise value
$5.4B

Footer menu